Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
New York Science Journal
2015 Standout
Mesenchymal Stem Cells for Chronic Wound Healing: Current Status of Preclinical and Clinical Studies
2020
Angiogenic and Osteogenic Potential of Bone Repair Cells for Craniofacial Regeneration
2010
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
A review of 122 published outcomes of danaparoid anticoagulation for intermittent haemodialysis
2009
The endothelial glycocalyx: composition, functions, and visualization
2007 Standout
The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes
2018 Standout
Preclinical and clinical evidence for stem cell therapies as treatment for diabetic wounds
2015
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
2006
Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes
2007
Drug-induced thrombocytopenia in critically ill patients
2010
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
2007 Standout
Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasma
2012
Molecular biology of the hepatitis C virus
1994
Receptor-targeting mechanisms of pain-causing toxins: How ow?
2012 StandoutNobel
Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies
2003
The immune system in atherosclerosis
2011 Standout
Mechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing
2019 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
The Antiphospholipid Syndrome
2002 Standout
Bone Tissue Engineering: Recent Advances and Challenges
2012 Standout
Activity of mesenchymal stem cells in therapies for chronic skin wound healing
2013
Analysis of a Successful Immune Response against Hepatitis C Virus
1999 StandoutNobel
Impact of platelet count on results obtained from multiple electrode platelet aggregometry (Multiplate™)
2010
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Tissue Factor Pathway and the Antiphospholipid Syndrome
2000
Origin and physiological roles of inflammation
2008 StandoutNature
Impaired T-cell differentiation in diabetic foot ulceration
2016
Advances in CD4 cell enumeration in resource-poor countries
2007
Mechanisms of plaque vulnerability and rupture
2003
Tissue factor pathway inhibitor: structure, biology and involvement in disease
2005
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Factor V Leiden: A Clinical Review
2001
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Elastomers for biomedical applications
1998
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
The Role of MicroRNAs in Diabetic Complications—Special Emphasis on Wound Healing
2014
Regulation of Functions of Vascular Wall Cells by Tissue Factor Pathway Inhibitor
2002
Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation
2008
Guidelines for the Primary Prevention of Stroke
2014 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Vascular Smooth Muscle Cell Senescence Promotes Atherosclerosis and Features of Plaque Vulnerability
2015
Risk Factor Associations With the Presence of a Lipid Core in Carotid Plaque of Asymptomatic Individuals Using High-Resolution MRI
2008
Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses
2002
Point-of-Care Diagnostics for Global Health
2008 Standout
Vascular Smooth Muscle Cells in Atherosclerosis
2016 Standout
Modulating the Vascular Response to Limb Ischemia
2015
Metallic implant biomaterials
2014 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Immunology of Acute and Chronic Wound Healing
2021 Standout
Works of W. Prohaska being referenced
Improved Detection of Hepatitis C Virus RNA by Reverse Transcription and Polymerase Chain Reaction
1992
Synthesis of Tissue Factor Pathway Inhibitor in Human Synovial Cells and Chondrocytes Makes Joints the Predilected Site of Bleeding in Haemophiliacs
1994
Evaluation of a New Reagent for Preserving Fresh Blood Samples and Its Potential Usefulness for Internal Quality Controls of Multichannel Hematology Analyzers
1999
IgG classification of anti‐PF4/heparin antibodies to identify patients with heparin‐induced thrombocytopenia during mechanical circulatory support
2007
Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients
2012
Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support
2006
Evidence against heterozygous coagulation factor V 1691 G?A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction
1995
Good Manufacturing Practice-Compliant Expansion of Marrow-Derived Stem and Progenitor Cells for Cell Therapy
2007
A First Mutation in the Human Tissue Factor Pathway Inhibitor Gene Encoding [P151L]TFPI
1998
In vitro blood compatibility of glow discharge‐grafted silicone rubber tubings
1988
The 536C→T Transition in the Human Tissue Factor Pathway Inhibitor (TFPI) Gene Is Statistically Associated with a Higher Risk for Venous Thrombosis
1999
A First Mutation in the Human Tissue Factor Pathway Inhibitor Gene Encoding [P151L]TFPI
1998
Preoperative haemostasis testing does not predict requirement of blood products in cardiac surgery.
2008